The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Cutting Edge: Inflammatory Responses Can Be Triggered by TREM-1, a Novel Receptor Expressed on Neutrophils and Monocytes
Abstract
We have identified new activating receptors of the Ig superfamily expressed on human myeloid cells, called TREM (triggering receptor expressed on myeloid cells). TREM-1 is selectively expressed on blood neutrophils and a subset of monocytes and is up-regulated by bacterial LPS. Engagement of TREM-1 triggers secretion of IL-8, monocyte chemotactic protein-1, and TNF-alpha and induces neutrophil degranulation. Intracellularly, TREM-1 induces Ca2+ mobilization and tyrosine phosphorylation of extracellular signal-related kinase 1 (ERK1), ERK2 and phospholipase C-gamma. To mediate activation, TREM-1 associates with the transmembrane adapter molecule DAP12. Thus, TREM-1 mediates activation of neutrophil and monocytes, and may have a predominant role in inflammatory responses.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“TREM2 expression was first observed in macrophages and dendritic cells, but not granulocytes or monocytes (9–11).”
From Trem2 promotes anti-inflammatory responses in microglia and is suppressed under pro-inflammatory conditions (2020) · cites this paper as [9]
Citations
Cites
Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm
Springer, T. A. (1994) · Cell · doi:10.1016/0092-8674(94)90337-9 · Cited by 7,009
Lanier, L. L. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.359 · Cited by 1,641
Recognition of Gram-negative bacteria and endotoxin by the innate immune system
Ulevitch, R. J., & Tobias, P. S. (1999) · Current Opinion in Immunology · doi:10.1016/s0952-7915(99)80004-1 · Cited by 567
Cantoni, C., Bottino, C., Vitale, M., Pessino, A. M., Augugliaro, R., Malaspina, A., Parolini, S., Moretta, L., Moretta, A., & Biassoni, R. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.5.787 · Cited by 450
Cella, M., Döhring, C., Samaridis, J., Dessing, M., Brockhaus, M., Lanzavecchia, A., & Colonna, M. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.10.1743 · Cited by 430
Bakker, A. B. H., Baker, E. G., Sutherland, G. R., Phillips, J. H., & Lanier, L. L. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.17.9792 · Cited by 210
Nakajima, H., Samaridis, J., Ångman, L., & Colonna, M. (1999) · PubMed · Cited by 173
Dietrich, J., Cella, M., Seiffert, M., Bühring, H., & Colonna, M. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.1.9 · Cited by 172
Nakajima, H., Samaridis, J., Ångman, L., & Colonna, M. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.1.5 · Cited by 152
Kubagawa, H., Chen, C., Ho, L. H., Shimada, T., Gartland, L., Mashburn, C. B., Uehara, T., Ravetch, J. V., & Cooper, M. D. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.2.309 · Cited by 148
Flagged first, then by citations
Research works printed but not linked: 13
- 1999, Curr. Opin. Immunol., 19
- 1995, Semin. Cell Biol., 345
- 1999, J. Immunol., 5
- 1998, J. Immunol., 4042
- 1999, J. Exp. Med., 309
- 2000, J. Immunol., 9
- 1999, Proc. Natl. Acad. Sci. USA, 9792
- 1998, Annu. Rev. Immunol., 359
- 1999, J. Exp. Med., 787
- 1991, Trends Biotechnol., 109
- 1997, J. Exp. Med., 1743
- 1997, The Leukocyte Antigen Facts Book
- 1994, Cell, 301
Cited by
Sorted by citations
Items 101–200 of 1,000
Lue, L., Schmitz, C. T., Serrano, G., Sue, L. I., Beach, T. G., & Walker, D. G. (2015) · Brain Pathology · doi:10.1111/bpa.12190 · Cited by 154
“In contrast to TREM2, the interaction of TREM1 with DAP12 leads to activation of NFκB pathway with proinflammatory consequence (4).”
BackgroundJoerink, M., Ribeiro, C. M. S., Stet, R. J. M., Hermsen, T., Savelkoul, H. F. J., & Wiegertjes, G. F. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.1.61 · Cited by 159
“TREM-1 expression is up-regulated in myeloid cells after LPS stimulation (45) or during sepsis (49).”
BackgroundTREM2 Function in Alzheimer’s Disease and Neurodegeneration
Ulrich, J. D., & Holtzman, D. M. (2016) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5b00313 · Cited by 154
Divergent and convergent evolution of NK-cell receptors
Barten, R., Torkar, M., Haude, A., Trowsdale, J., & Wilson, M. J. (2001) · Trends in Immunology · doi:10.1016/s1471-4906(00)01802-0 · Cited by 154
TREM2 is associated with increased risk for Alzheimer’s disease in African Americans
Jin, S. C., Carrasquillo, M. M., Benitez, B. A., Skorupa, T., Carrell, D., Patel, D., Lincoln, S., Krishnan, S., Kachadoorian, M., Reitz, C., et al. (2015) · Molecular Neurodegeneration · doi:10.1186/s13024-015-0016-9 · Cited by 153
“Background TREM2 is a transmembrane receptor expressed on microglia, macrophages, monocyte-derived dendritic cells, and osteoclasts [1,2].”
BackgroundBianchin, M., Capella, H., Chaves, D. L., Steindel, M., Grisard, E., Ganev, G. G., da Silva, J. P., Schaeffer, E., Poffo, M. A., Walz, R., et al. (2004) · Cellular and molecular neurobiology · doi:10.1023/b:cemn.0000012721.08168.ee · Cited by 147
“Moreover, considering a theoretical possible role of DAP12 in the normal function of NK cells (Bakker et al., 2000; Bouchon et al., 2000, 2001; Campbell and Colonna, 1999; Lanier, 1998; Lanier and Bakker, 2000; Paloneva et al., 2000; Sjolin et al., 2002), it is interesting to observe that there is…”
BackgroundMarkers for Sepsis Diagnosis: What is Useful?
Reinhart, K., Meisner, M., & Brunkhorst, F. M. (2006) · Critical Care Clinics · doi:10.1016/j.ccc.2006.03.003 · Cited by 155
“Triggering receptor expressed on myeloid cells-1 (TREM-1) is a recently identified cell surface molecule, a member of the immunoglobulin superfamily, which is expressed on human neutrophils and monocytes and triggers secretions of proinflammatory mediators, such as IL-8, tumor necrosis factor-a, and IL-1b [51].”
BackgroundTREM-1 Expression in Tumor-associated Macrophages and Clinical Outcome in Lung Cancer
Ho, C., Liao, W., Wang, C.-Y., Lu, Y.-H., Huang, H., Chen, H., Chan, W., Chen, H., & Yang, P. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200704-641oc · Cited by 150
Transepithelial migration of neutrophils into the lung requires TREM-1
Klesney‐Tait, J., Keck, K., Li, X., Gilfillan, S., Otero, K., Baruah, S., Meyerholz, D. K., Varga, S. M., Knudson, C. J., Moninger, T. O., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci64181 · Cited by 149
“TREM-1, which was initially discovered on human neutrophils and monocytes, has been studied in patients with pneumonia and sepsis (6, 7).”
Giraldo, M., Lopera, F., Siniard, A. L., Corneveaux, J. J., Schrauwen, I., Carvajal, J., Muñoz, C., Ramirez-Restrepo, M., Gaiteri, C., Myers, A. J., et al. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.02.016 · Cited by 147
“1), leaving the extracellular and transmembrane part of the protein almost intact, but missing the short cytoplasmic domain (Bouchon et al., 2000).”
BackgroundInfluentialKnapp, S., Gibot, S., de Vos, A. F., Versteeg, H. H., Colonna, M., & van der Poll, T. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.12.7131 · Cited by 149
“ulocytes, monocytes, and a subset of macrophages (3, 4).”
BackgroundMethodInfluentialRaj, T., Ryan, K. J., Replogle, J. M., Chibnik, L. B., Rosenkrantz, L., Tang, A., Rothamel, K., Stranger, B. E., Bennett, D. A., Evans, D. A., et al. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddt666 · Cited by 144
“Our exon-level analysis of CD33 expression highlights an emerging role for an infiltrating macrophage and/or microglial activation network (including the genes TYROBP, CD33 and TREM2) in modulating AD susceptibility and pathology.”
BackgroundInfluentialBiomarkers for Sepsis: What is and What Might Be?
Girard, B., Ayala, A., & Lomas‐Neira, J. (2015) · Biomarker Insights · doi:10.4137/bmi.s29519 · Cited by 149
The extended human leukocyte receptor complex: diverse ways of modulating immune responses
Barrow, A. D., & Trowsdale, J. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00653.x · Cited by 147
Gene Expression Pattern of Cells From Inflamed and Normal Areas of Osteoarthritis Synovial Membrane
Lambert, C., Dubuc, J., Montell, E., Vergés, J., Munaut, C., Noël, A., & Henrotin, Y. E. (2013) · Arthritis & Rheumatology · doi:10.1002/art.38315 · Cited by 141
Gibot, S., & Cravoisy, A. (2004) · Clinical Medicine & Research · doi:10.3121/cmr.2.3.181 · Cited by 140
Washington, A. V., Gibot, S., Acevedo, I., Gattis, J., Quigley, L., Feltz, R., Mota, A. D. L., Schubert, R. L., Gómez‐Rodríguez, J., Cheng, J., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci36175 · Cited by 142
Vitamin D-Mediated Induction of Innate Immunity in Gingival Epithelial Cells
McMahon, L., Schwartz, K., Yilmaz, Ö., Brown, E., Ryan, L. K., & Diamond, G. (2011) · Infection and Immunity · doi:10.1128/iai.00099-11 · Cited by 141
TREM-1, MDL-1, and DAP12 expression is associated with a mature stage of myeloid development
Gingras, M., Lapillonne, H., & Margolin, J. (2002) · Molecular Immunology · doi:10.1016/s0161-5890(02)00004-4 · Cited by 141
Fortin, C. F., Lesur, O., & Fülöp, T. (2006) · International Immunology · doi:10.1093/intimm/dxl119 · Cited by 140
Dai, X., Zeng, Z., Fu, C., Zhang, S.-A., Cai, Y., & Chen, Z. (2015) · Critical Care · doi:10.1186/s13054-015-0941-6 · Cited by 138
“The expression of TREM, a glycoprotein of the immunoglobulin superfamily, in neutrophils and monocytes is upregulated in the presence of infection [23,24].”
BackgroundNon-parenchymal TREM-2 protects the liver from immune-mediated hepatocellular damage
Perugorria, M. J., Esparza-Baquer, A., Oakley, F., Labiano, I., Korosec, A., Jais, A., Mann, J., Tiniakos, D., Santos-Laso, A., Arbelaiz, A., et al. (2019) · Gut · doi:10.1136/gutjnl-2017-314107 · Cited by 144
Zhong, L., Chen, X.-F., Zhang, Z.-L., Wang, Z., Shi, X.-Z., Xu, K., Zhang, Y.-W., Xu, H., & Bu, G. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.645986 · Cited by 133
“Given TREM1, in contrast to TREM2, serves as a critical amplifier of inflammatory signaling (14, 15), DAP12 could modulate either a pro-inflammatory or anti-inflammatory response depending on the upstream receptor partner.”
BackgroundYin, X., Yu, H., Jin, X., Li, J., Guo, H., Shi, Q., Yin, Z., Xu, Y., Wang, X., Liu, R., et al. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1600193 · Cited by 132
“increased levels of monocyte/macrophage-specific molecules such as CD14, CD163 (44), FCN1 (45), S100A8, S100A9 (46), C5AR1 (47), MRC1 (48) and TREM-1 (49) (Table II).”
Extracellular CIRP as an endogenous TREM-1 ligand to fuel inflammation in sepsis
Denning, N., Aziz, M., Murao, A., Gurien, S. D., Ochani, M., Prince, J. M., & Wang, P. (2020) · JCI Insight · doi:10.1172/jci.insight.134172 · Cited by 131
“Additionally, simultaneous activation of TREM-1 and TLR4 leads to synergistic production of proinflammatory mediators through common signaling pathway activation including PI3K, ERK1/2, IRAK1 and NF-κB activation (13-16).”
BackgroundMethodInfluentialHu, X., Liou, A. K. F., Leak, R. K., Xu, M., An, C., Suenaga, J., Shi, Y., Gao, Y., Zheng, P., & Chen, J. (2014) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2014.06.002 · Cited by 139
Biomarkers of sepsis: clinically useful?
Meisner, M. (2005) · Current Opinion in Critical Care · doi:10.1097/01.ccx.0000176694.92883.ce · Cited by 131
Development and Validation of a Multiplex Add-On Assay for Sepsis Biomarkers Using xMAP Technology
Kofoed, K., Schneider, U. V., Scheel, T. K. H., Andersen, O., & Eugen‐Olsen, J. (2006) · Clinical Chemistry · doi:10.1373/clinchem.2006.067595 · Cited by 130
TREM-1 Deficiency Can Attenuate Disease Severity without Affecting Pathogen Clearance
Weber, B., Schuster, S., Zysset, D., Rihs, S., Dickgreber, N., Schürch, C. M., Riether, C., Siegrist, M., Schneider, C., Pawelski, H., et al. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1003900 · Cited by 129
“In contrast to the fairly ubiquitously expressed TLRs and NOD-like receptors, expression of TREMs is restricted to cells of the myeloid lineage [4].”
BackgroundInfluentialCheng, Q., Danao, J., Talreja, S., Wen, P. H., Yin, J., Sun, N., Li, C.-M., Chui, D., Tran, D. T., Koirala, S., et al. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.001848 · Cited by 129
“inflammatory response (pro-inflammatory versus anti-inflammatory) (22); similarly, TREML1 and TREML2 also modulate inflammatory response; in fact, TREML2 is expressed on similar cells as TREM2, including microglia, and recently has been proposed to play an opposing role to TREM2 (23, 24).”
BackgroundFunctional genomics of silencing TREM-1 on TLR4 signaling in macrophages
Ornatowska, M., Azim, A. C., Wang, X., Christman, J. W., Xiao, L., Joo, M., & Sadikot, R. T. (2007) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00140.2007 · Cited by 134
“TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 1 (TREM-1) is a newly identified member of the immunoglobulin superfamily of receptors present on the macrophage and neutrophils that has also shown to be involved in the triggering of the inflammatory response (4, 5, 7, 8).”
BackgroundNetea, M. G., Azam, T., Ferwerda, G., Girardin, S. E., Kim, S.-H., & Dinarello, C. A. (2006) · Journal of Leukocyte Biology · doi:10.1189/jlb.1205758 · Cited by 129
Microglial inflammation and phagocytosis in Alzheimer's disease: Potential therapeutic targets
Nizami, S., Hall‐Roberts, H., Warrier, S., Cowley, S. A., & Di Daniel, E. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14618 · Cited by 147
Weber, B., Saurer, L., Schenk, M., Dickgreber, N., & Mueller, C. (2011) · European Journal of Immunology · doi:10.1002/eji.201040965 · Cited by 128
Heine, H., Rietschel, E., & Ulmer, A. J. (2001) · Molecular Biotechnology · doi:10.1385/mb:19:3:279 · Cited by 133
The Effect of Triptolide in Rheumatoid Arthritis: From Basic Research towards Clinical Translation
Fan, D., Guo, Q., Shen, J., Zheng, K., Lu, C. C., Zhang, G., Lü, A., & He, X. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19020376 · Cited by 127
“Triggering receptor expressed on myeloid cells (TREM)-1 is a member of the Ig superfamily, and its activation can result in an inflammatory reaction [37,38].”
BackgroundA TREM family member, TLT-1, is found exclusively in the α-granules of megakaryocytes and platelets
Washington, A. V., Schubert, R. L., Quigley, L., DiSipio, T. C., Feltz, R., Cho, E. H., & McVicar, D. W. (2004) · Blood · doi:10.1182/blood-2004-01-0315 · Cited by 125
Bosco, M. C., Pierobon, D., Blengio, F., Raggi, F., Vanni, C., Gattorno, M., Eva, A., Novelli, F., Cappello, P., Giovarelli, M., et al. (2010) · Blood · doi:10.1182/blood-2010-06-292136 · Cited by 125
Cioni, B., Zaalberg, A., B, J. R. V. B., Melis, M. H. M., van Burgsteden, J. A., Muraro, M. J., Hooijberg, E., Peters, D. D. G. C., Hofland, I., Lubeck, Y., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-18313-y · Cited by 128
Wu, Y., Wang, F., Fan, X., Bao, R., Bo, L., Li, J., & Deng, X. (2012) · Critical Care · doi:10.1186/cc11884 · Cited by 119
“Human tissues infected with bacteria were infiltrated with neutrophils and monocytes that expressed high levels of TREM-1 [8,46].”
BackgroundSoluble Trem-like Transcript-1 Regulates Leukocyte Activation and Controls Microbial Sepsis
Derive, M., Bouazza, Y., Sennoun, N., Marchionni, S., Quigley, L., Washington, A. V., Massin, F., Max, J., Ford, J. W., Alauzet, C., et al. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1102674 · Cited by 119
Ren, M., Guo, Y., Wei, X., Yan, S., Qin, Y., Zhang, X., Jiang, F., & Lou, H. (2018) · Experimental Neurology · doi:10.1016/j.expneurol.2018.01.016 · Cited by 119
“Triggering receptor expressed on myeloid cells-2 (TREM2) is a cellsurface receptor of the Ig superfamily that is expressed in tissue macrophages, osteoclasts, and microglia (Bouchon et al., 2000).”
Mechanisms and Potential Therapeutic Applications of Microglial Activation after Brain Injury
Kim, J. Y., Kim, N., & Yenari, M. A. (2014) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12360 · Cited by 125
“Activation of TREM1 on monocytes and neutrophils boosts secretion of pro-inflammatory cytokines and chemokines and mediates the upregulation of cell-surface molecules involved in extravasation, cell activation, and costimulation [77].”
BackgroundJiang, T., Yu, J., Zhu, X., & Tan, L. (2013) · Molecular Neurobiology · doi:10.1007/s12035-013-8424-8 · Cited by 122
“The five exons of the TREM2 gene code for a 693-bp complementary DNA that is translated into a 230 amino acid polypeptide, called TREM2 [10].”
BackgroundProteomic analysis of palmitoylated platelet proteins
Dowal, L. M., Yang, W., Freeman, M. R., et al. (2011) · Blood · doi:10.1182/blood-2011-05-353078 · Cited by 117
Pal, S., Bhattacharjee, A., Ali, A., Mandal, N. C., Mandal, S. C., & Pal, M. (2014) · Journal of Inflammation · doi:10.1186/1476-9255-11-23 · Cited by 119
Mucosal macrophages and the regulation of immune responses in the intestine
Platt, A. M., & Mowat, A. M. (2008) · Immunology Letters · doi:10.1016/j.imlet.2008.05.009 · Cited by 120
Bieren, J. E., Mosconi, I., Guiet, R., Piersgilli, A., Volpe, B., Chen, F., Gause, W. C., Seitz, A., Verbeek, J. S., & Harris, N. L. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003771 · Cited by 112
“5 Induction of immune responses [80],[81], inflammatory response to Schistosoma [82]”
BackgroundDePaula-Silva, A. B., Gorbea, C., Doty, D. J., Libbey, J. E., Sanchez, J. M. S., Hanak, T. J., Cazalla, D., & Fujinami, R. S. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1545-x · Cited by 133
Biomarkers: Diagnosis and Risk Assessment in Sepsis
Ventetuolo, C. E., & Levy, M. M. (2008) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2008.07.001 · Cited by 116
“TREM-1, part of the immunoglobulin superfamily, is up-regulated in response to bacteria or fungi and, when bound to ligand, stimulates release of such cytokines via signal transduction molecule DAP12.(87,88) Healthy volunteers injected with lipopolysaccharide(89) and patients with septic shock have been shown to have…”
BackgroundNeutrophil-specific deletion of Syk kinase results in reduced host defense to bacterial infection
Ziffle, J. V., & Lowell, C. A. (2009) · Blood · doi:10.1182/blood-2009-05-220806 · Cited by 119
Dhiman, K., Blennow, K., Zetterberg, H., Martins, R. N., & Gupta, V. B. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03040-5 · Cited by 117
Schenk, M., Bouchon, A., Birrer, S., Colonna, M., & Mueller, C. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.1.517 · Cited by 114
“TREM-1 is selectively expressed on the cell surface of neutrophils and subsets of monocytes and tissue macrophages (21).”
BackgroundInfluentialCMRF-35-Like Molecule-1, a Novel Mouse Myeloid Receptor, Can Inhibit Osteoclast Formation
Chung, D.-H., Humphrey, M. B., Nakamura, M. C., Ginzinger, D. G., Seaman, W. E., & Daws, M. R. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.12.6541 · Cited by 113
Gibot, S., Buonsanti, C., Massin, F., Romano, M., Kolopp‐Sarda, M., Benigni, F., Faure, G. C., Béné, M. C., Panina‐Bordignon, P., Passini, N., et al. (2006) · Infection and Immunity · doi:10.1128/iai.74.5.2823-2830.2006 · Cited by 112
“Recently, a new family of receptors expressed on myeloid cells (the triggering receptor expressed on myeloid cells [TREM]), distantly related to NKp44, has been described (2, 8).”
BackgroundCiani, I., Schulze, H., Corrigan, D. K., et al. (2011) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2011.11.004 · Cited by 110
Va, M., Thi, V. L. D., & Denner, J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0070399 · Cited by 109
“TREM-1 has a role as a regulator of innate and adaptive immunity [30,31].”
BackgroundTREM2 brain transcript-specific studies in AD and TREM2 mutation carriers
Del‐Aguila, J. L., Benítez, B. A., Li, Z., Dube, U., Mihindukulasuriya, K. A., Budde, J., Farias, F., Fernández, M. V., Ibáñez, L., Jiang, S., et al. (2019) · Molecular Neurodegeneration · doi:10.1186/s13024-019-0319-3 · Cited by 106
“Introduction The Triggering Receptor Expressed in Myeloid cells 2 (TREM2) is a type 1 transmembrane receptor protein expressed on myeloid cells including microglia, monocyte-derived dendritic cells, osteoclasts and bone-marrow derived macrophages [1, 2].”
BackgroundModulation of Angiogenic and Inflammatory Response in Glioblastoma by Hypoxia
Murat, A., Migliavacca, E., Hussain, S. F., Heimberger, A. B., Desbaillets, I., Hamou, M., Rüegg, C., Stupp, R., Delorenzi, M., & Hegi, M. E. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005947 · Cited by 108
“Once recruited, tumor-educated macrophages take on non-immunological functions, in particular the production of factors that promote progression of tumors to a more malignant state through paracrine cues, including angiogenic factors (VEGF, TNF-a, ANG1), proteases (MMPs), growth factors (FGF, PDGF, TGF-b), and motilit…”
BackgroundYotsumoto, K., Okoshi, Y., Shibuya, K., et al. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021825 · Cited by 108
Joffre, J., Potteaux, S., Zeboudj, L., Loyer, X., Boufenzer, A., Laurans, L., Esposito, B., Vandestienne, M., de Jager, S. C. A., Hénique, C., et al. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.10.015 · Cited by 117
“Data are expressed as median and percentiles (5-95).”
BackgroundInfluentialMohamadzadeh, M., Coberley, S. S., Olinger, G. G., Kalina, W. V., Ruthel, G. T., Fuller, C. L., Swenson, D. L., Pratt, W. D., Kuhns, D. B., & Schmaljohn, A. L. (2006) · Journal of Virology · doi:10.1128/jvi.00543-06 · Cited by 107
“Activation of DAP12-coupled receptors results in transient tyrosine phosphorylation of ITAM chains, recruits and promotes activation of the tyrosine kinase Syk, and subsequently leads to activation of extracellular signal-regulated kinases 1/2 (ERK1/2) (33), resulting in the secretion of primary neutrophil cytokines a…”
BackgroundInfluentialTriggering receptor expressed on myeloid cells-1 (TREM-1): a new player in antiviral immunity?
Roe, K., Gibot, S., & Verma, S. (2014) · Frontiers in Microbiology · doi:10.3389/fmicb.2014.00627 · Cited by 107
“Activation of TREM-1 signaling is initiated upon binding of the ligand to the receptor, which triggers the association and phosphorylation of immunoreceptor tyrosine-based activation motif of the adaptor protein DAP12.”
BackgroundInfluentialFan, D., He, X., Bian, Y., Guo, Q., Zheng, K., Zhao, Y., Lu, C. C., Liu, B.-Q., Xu, X., Zhang, G., et al. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17040498 · Cited by 107
“Although the natural ligand of TREM-1 is unknown, activation of TREM-1 using an agonistic antibody leads to activation of a cascade of intracellular events which result in inflammatory effects, such as neutrophils degranulation, phagocytosis, and the proinflammatory chemokines production including monocyte chemoattrac…”
BackgroundThe Pathogenesis of Glaucoma in the Interplay with the Immune System
Rieck, J. (2013) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.12-9781 · Cited by 104
Structure, expression pattern and biological activity of molecular complex TREM-2/DAP12
Paradowska-Gorycka, A., & Jurkowska, M. (2013) · Human Immunology · doi:10.1016/j.humimm.2013.02.003 · Cited by 103
“The cytoplasmic tail of TREM-2 lacks signaling motifs; therefore a separate signal transduction subunit is required to mediate TREM-2 activating signals [30,31,33].”
BackgroundThe innate immune receptor TREM-1 promotes liver injury and fibrosis
Nguyen-Lefebvre, A. T., Ajith, A., Portik-Dobos, V., Horuzsko, D. D., Arbab, A. S., Dzutsev, A., Sadek, R., Trinchieri, G., & Horuzsko, A. (2018) · Journal of Clinical Investigation · doi:10.1172/jci98156 · Cited by 104
“TREM-1 is expressed on neutrophils, monocytes, and macrophages, where it is upregulated during infection, cancer development, and following TLR engagement (16, 17).”
InfluentialThrash, J. C., Torbett, B. E., & Carson, M. J. (2008) · Neurochemical Research · doi:10.1007/s11064-008-9657-1 · Cited by 103
Bédard, A., Tremblay, P., Chernomoretz, A., & Vallières, L. (2007) · Glia · doi:10.1002/glia.20477 · Cited by 103
“, 2005), was strongly expressed in these cells, but not in the other types examined, as anticipated from previous studies (Bouchon et al., 2000; Schmid et al., 2002).”
ResultInfluentialCollins, C. E., La, D. T., Yang, H.-T., et al. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.089557 · Cited by 101
“Whereas crosslinking of TREM-1 alone induces modest cellular activation and proinflammatory cytokine secretion, TREM-1 acts synergistically with receptors for pathogenassociated molecular patterns (PAMPs) [3-5, 7].”
BackgroundResultInfluentialImmunoreceptors on neutrophils
van Rees, D. J., Szilagyi, K., Kuijpers, T. W., Matlung, H. L., & van den Berg, T. K. (2016) · Seminars in Immunology · doi:10.1016/j.smim.2016.02.004 · Cited by 100
“Additionally, human and mice also express TREM-like transcripts (TLT)-1 and -2 [145, 146] , but only TREM-1 and TLT-2 are expressed on neutrophils [147, 148] .”
BackgroundAdvanced Role of Neutrophils in Common Respiratory Diseases
Liu, J., Pang, Z., Wang, G., Guan, X., Fang, K., Wang, Z., & Wang, F. (2017) · Journal of Immunology Research · doi:10.1155/2017/6710278 · Cited by 109
“Triggering receptor expressed on myeloid cells-1 (TREM-1) is a receptor on phagocytes known to amplify TLR- and NOD-like receptor inflammatory signaling [136, 137].”
BackgroundClinical review: role of triggering receptor expressed on myeloid cells-1 during sepsis.
Gibot, S. (2005) · Critical Care · doi:10.1186/cc3732 · Cited by 101
“TREM-1 as an amplifier of the inflammatory response TREM-1 is expressed by neutrophils, macrophages and mature monocytes [5].”
BackgroundInfluentialAminophospholipids are signal-transducing TREM2 ligands on apoptotic cells
Shirotani, K., Hori, Y., Yoshizaki, R., Higuchi, E., Colonna, M., Saito, T., Hashimoto, S., Saito, T., Saido, T. C., & Iwata, N. (2019) · Scientific Reports · doi:10.1038/s41598-019-43535-6 · Cited by 116
TREM-1 multimerization is essential for its activation on monocytes and neutrophils
Carrasco, K., Boufenzer, A., Jolly, L., Cordier, H. L., Wang, G., Heck, A. J. R., Cerwenka, A., Vinolo, E., Nazabal, A., Kriznik, A., et al. (2018) · Cellular and Molecular Immunology · doi:10.1038/s41423-018-0003-5 · Cited by 100
TREM-1: A new regulator of innate immunity in sepsis syndrome
Nathan, C., & Ding, A. H. (2001) · Nature Medicine · doi:10.1038/87846 · Cited by 100
TREM‐1 promotes survival during septic shock in mice
Gibot, S., Massin, F., Marcou, M., Taylor, V., Stidwill, R. P., Wilson, P., Singer, M., & Bellingan, G. J. (2007) · European Journal of Immunology · doi:10.1002/eji.200636387 · Cited by 100
Barnea, E., Beer, I., Patoka, R., Ziv, T., Kessler, O., Tzehoval, E., Eisenbach, L., Zavazava, N., & Admon, A. (2002) · European Journal of Immunology · doi:10.1002/1521-4141(200201)32:1 · Cited by 92
Cantoni, C., Ponassi, M., Biassoni, R., Conte, R., Spallarossa, A., Moretta, A., Moretta, L., Bolognesi, M., & Bordo, D. (2003) · Structure · doi:10.1016/s0969-2126(03)00095-9 · Cited by 100
Desale, S. E., Chidambaram, H., & Chinnathambi, S. (2021) · Molecular Biomedicine · doi:10.1186/s43556-021-00036-1 · Cited by 99
The systemic inflammatory response syndrome
Weigand, M. A., Hörner, C., Bardenheuer, H. J., & Bouchon, A. (2004) · Best practice & research. Clinical anaesthesiology · doi:10.1016/j.bpa.2003.12.005 · Cited by 98
DAP12 (KARAP) amplifies inflammation and increases mortality from endotoxemia and septic peritonitis
Turnbull, I. R., McDunn, J. E., Takai, T., Townsend, R. R., Cobb, J. P., & Colonna, M. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050986 · Cited by 99
“Therefore, it is possible that high concentrations of LPS, elevated inflammatory cytokines, and an extended time course of inflammation in simple endotoxemia may induce the expression of high affinity DAP12-associated receptor–ligand pairs that can synergize with TLR-mediated pathways to drive cytokine production as d…”
BackgroundInfluentialMicrobes-induced EMT at the crossroad of inflammation and cancer
Hofman, P. M., & Vouret‐Craviari, V. (2012) · Gut Microbes · doi:10.4161/gmic.20288 · Cited by 95
Aging and Neutrophils: There Is Still Much To Do
Fortin, C. F., McDonald, P. P., Lesur, O., & Fülöp, T. (2008) · Rejuvenation Research · doi:10.1089/rej.2008.0750 · Cited by 97
“45 TREM-1 is on the surface of PMNs and monocytes, and bacterial lipopolysaccharides (LPS) induce its expression.”
Surface triggering receptor expressed on myeloid cells 1 expression patterns in septic shock
Gibot, S., Renard, P. L., Bollaert, P., Kolopp‐Sarda, M., Béné, M. C., Faure, G. C., & L�vy, B. (2005) · Intensive Care Medicine · doi:10.1007/s00134-005-2572-x · Cited by 93
DAP12: an adapter protein with dual functionality
Takaki, R., Watson, S. R., & Lanier, L. L. (2006) · Immunological Reviews · doi:10.1111/j.1600-065x.2006.00466.x · Cited by 91
“Signaling through TREM-1 has been shown to intersect the TLR signaling pathway and augment the TLRinduced immune response mediated by neutrophils and monocytes (18, 19).”
BackgroundInnate immune recognition by stimulatory immunoreceptors
Diefenbach, A., & Raulet, D. H. (2003) · Current Opinion in Immunology · doi:10.1016/s0952-7915(02)00007-9 · Cited by 93
ITIM receptors: more than just inhibitors of platelet activation
Coxon, C. H., Geer, M. J., & Senis, Y. A. (2017) · Blood · doi:10.1182/blood-2016-12-720185 · Cited by 92
Merck, E., Gaillard, C., Gorman, D. M., Montero‐Julian, F. A., Durand, I., Zurawski, S., Ménétrier‐Caux, C., Carra, G., Lebecque, S., Trinchieri, G., et al. (2004) · Blood · doi:10.1182/blood-2004-03-0850 · Cited by 92
Regulation of TREM expression in hepatic macrophages and endothelial cells during acute endotoxemia
Chen, L. C., Laskin, J. D., Gordon, M. K., & Laskin, D. L. (2007) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2007.11.004 · Cited by 90
“Activation of TREM-1 is associated with release of proinflammatory mediators and reactive oxygen and nitrogen intermediates by phagocytic leukocytes (Bouchon et al., 2000; Gibot et al., 2007; Radsak et al., 2004).”
BackgroundSchulz, A., Toedt, G., Zenz, T., Stilgenbauer, S., Lichter, P., & Seiffert, M. (2011) · Haematologica · doi:10.3324/haematol.2010.031377 · Cited by 100
“immune responses in cooperation with Toll-like receptors and in inflammatory processes.(34) Immune-related and inflammatory conditions have been recognized to be of importance in the pathogenesis of CLL, and anti-inflammatory drugs are currently being tested as potential therapeutic agents for CLL patients.”
BackgroundKuai, J., Gregory, B., Hill, A., Pittman, D. D., Feldman, J. L., Brown, T., Carito, B. A., O’Toole, M., Ramsey, R., Adolfsson, O., et al. (2009) · Lara D. Veeken · doi:10.1093/rheumatology/kep235 · Cited by 92
Triggering receptor expressed on myeloid cells: role in the diagnosis of lung infections
Richeldi, L., Mariani, M., Losi, M., Maselli, F., Corbetta, L., Buonsanti, C., Colonna, M., Sinigaglia, F., Panina‐Bordignon, P., & Fabbri, L. M. (2004) · European Respiratory Journal · doi:10.1183/09031936.04.00014204 · Cited by 92
Vps35-dependent recycling of Trem2 regulates microglial function
Yin, J., Liu, X., He, Q., Zhou, L., Yuan, Z., & Zhao, S. (2016) · Traffic · doi:10.1111/tra.12451 · Cited by 90
“Trem2 consists of a leading signal peptide, a single type V extracellular region containing 3 potential N-glycosylation sites, a transmembrane domain and a short cytoplasmic tail lacking signaling motifs.(1) Owing to its short cytoplasmic tail, Trem2 needed to transfer its signaling by Dap12, an adaptor protein,(2) wh…”
TREM2 suppresses the proinflammatory response to facilitate PRRSV infection via PI3K/NF-κB signaling
Zhu, Z., Zhang, X., Dong, W., Wang, X., he, S. T., Zhang, H., Wang, X., Wei, R., Chen, Y., Liu, X., et al. (2020) · PLoS Pathogens · doi:10.1371/journal.ppat.1008543 · Cited by 91
“Triggering receptor expressed on myeloid cells 2 (TREM2) is a novel cell surface receptor, which was first identified in 2000 [21].”
BackgroundCurrent Evidence and Limitation of Biomarkers for Detecting Sepsis and Systemic Infection
Hung, S.-K., Lan, H.-M., Han, S.-T., Wu, C., & Chen, K. (2020) · Biomedicines · doi:10.3390/biomedicines8110494 · Cited by 94
Boufenzer, A., Carrasco, K., Jolly, L., Brustolin, B., Pillo, E. D., Derive, M., & Gibot, S. (2021) · Cellular and Molecular Immunology · doi:10.1038/s41423-020-00591-7 · Cited by 89
Lagler, H., Sharif, O., Haslinger, I., Matt, U., Stich, K., Furtner, T., Doninger, B., Schmid, K., Gattringer, R., de Vos, A. F., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803862 · Cited by 90
Jiyong, J., Tiancha, H., Cui, W., & Huahao, S. (2008) · Intensive Care Medicine · doi:10.1007/s00134-008-1333-z · Cited by 89
“The triggering receptor expressed on myeloid cells-1 (TREM-1) is a recently discovered member of the immunoglobulin super family, the expression of which on phagocytosis is up-regulated by exposure to bacteria and fungi [12].”
BackgroundInfluentialZhang, J., She, D., Feng, D., et al. (2011) · BMC Infectious Diseases · doi:10.1186/1471-2334-11-53 · Cited by 89
“in 2000 [1], is a member of the immunoglobulin superfamily of receptors that is specifically expressed on the surfaces of monocytes and neutrophils.”
Background
Metadata
- Authors
- Bouchon, A., Dietrich, J., & Colonna, M.
- Affiliations
- Basel Institute for Immunology , Basel ,
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2000-05
- Volume
- 164
- Issue
- 10
- Pages
- 4991-4995
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W2149698238
- Semantic Scholar
- c6fffd66acdcb27c928605f7aca443056a3a6c3f
- Cited by
- 1,284
- References
- 13
- Citations by year
- 2026: 38 · 2025: 47 · 2024: 73 · 2023: 87 · 2022: 51 · 2021: 65 · 2020: 83 · 2019: 49 · 2018: 55 · 2017: 51 · 2016: 59 · 2015: 47 · 2014: 48 · 2013: 68 · 2012: 50
- FWCI
- 6.50
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Immunology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Inflammation biomarkers and pathways
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Life Sciences › Immunology and Microbiology › Immunology › Neutrophil, Myeloperoxidase and Oxidative Mechanisms
- Keywords
- TREM-1, neutrophils, monocytes, inflammation, IL-8 secretion, MCP-1, TNF-α, neutrophil degranulation, calcium mobilization, phospholipase C-gamma, myeloid cell activation
- MeSH terms
- Triggering Receptor Expressed on Myeloid Cells-1, Amino Acid Sequence, Fungi, Multigene Family, Gram-Negative Bacteria, Gram-Positive Bacteria, Humans, Immunoglobulins, Inflammation, Macrophage Activation, Membrane Glycoproteins, Membrane Proteins, Molecular Sequence Data, Molecular Weight, Monocytes, Neutrophils, Phosphorylation, Receptors, Immunologic, Tyrosine, Biomarkers, Up-Regulation, Cytokines, Neutrophil Activation, Chemokines, Calcium Signaling, Adaptor Proteins, Signal Transducing
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review